Pharmacokinetics and Antitumor Effect of Doxorubicin Carried by Stealth and Remote Loading Proliposome
Pharmacokinetics and Antitumor Effect of Doxorubicin Carried by Stealth and Remote Loading Proliposome
复制标题
隐形远程装载前脂质体阿霉素的药代动力学及抗肿瘤作用
作者:
J. P. Wang;Y. Maitani;K. Takayama;T. Nagai
AbstractPurpose. The aim of the study was to prepare stealth and remoteloading proliposome (SRP-L) to carry doxorubicin (DXR) and evaluatethe pharmacokinetics, acute toxicity, and anticancer effect of DXRcarried with SRP-L.
Methods. SRP-L was transparent solution. When SRP-L was injectedinto 0.9% NaCl aqueous solution containing DXR, liposomes formedand automatically loaded DXR (SRP-L-DXR). The long circulation ofSRP-L-DXR was evaluated using the pharmacokinetics ofSRP-L-DXR, cardiolipin liposomal DXR (CL-DXR) and free DXR (F-DXR).The acute toxicity and anticancer effect of SRP-L-DXR were evaluatedin C57BL/6 mice and murine hystocytoma M5076 tumor model.
Results. The average diameter of SRP-L-DXR in pure water was112.9 ± 8.6 (nm) and the encapsulation efficiency of SRP-L-DXRwas 96.5 ± 0.2% in pure water, 95.5 ± 0.1% in 5% glucose and 98.01± 0.6% in 0.9% NaCl. The plasma concentration of SRP-L-DXR wasmuch higher than those of F-DXR and CL-DXR. Compared with thatof F-DXR, the SRP-L-DXR had lower acute toxicity and its anticancereffects depended upon the therapeutic treatment.
Conclusions. A novel proliposome (SRP-L) was developed, whichcould automatically load DXR and form SRP-L-DXR with excellentcharacteristics. SRP-L-DXR had lower acute toxicity but was notalways more effective for the treatment of the ascitic M5076 thanF-DXR.
影响因子:
11.2
作者:
Ning Z. Wu;Daphne Da;Tracy L. Rudoll;David Needham;A. Whorton;M. Dewhirst
通讯作者:
Ning Z. Wu;Daphne Da;Tracy L. Rudoll;David Needham;A. Whorton;M. Dewhirst
DOI:
10.1016/0005-2736(80)90558-1
发表时间:
1980-01-01
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
SZOKA, F;OLSON, F;PAPAHADJOPOULOS, D
通讯作者:
PAPAHADJOPOULOS, D
影响因子:
6.5
作者:
HamiltonJr,RL;Goerke,J;Guo,LS;Williams,MC;Havel,RJ
通讯作者:
Havel,RJ